newsfilter
← Latest News
GlobeNewswire·

Sol-Gel Announces Health Canada Approval of EPSOLAY®

NESS ZIONA, Israel, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ:SLGL), a dermatology company, pioneering treatments for patients with severe skin conditions, conducting a Phase-3 clinical